321 related articles for article (PubMed ID: 33992859)
1. Innate immunity and HBV persistence.
Chiale C; Marchese AM; Robek MD
Curr Opin Virol; 2021 Aug; 49():13-20. PubMed ID: 33992859
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
Ma Z; Zhang E; Yang D; Lu M
Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
[TBL] [Abstract][Full Text] [Related]
3. Adaptive immunity in HBV infection.
Bertoletti A; Ferrari C
J Hepatol; 2016 Apr; 64(1 Suppl):S71-S83. PubMed ID: 27084039
[TBL] [Abstract][Full Text] [Related]
4. The role of innate immunity in the immunopathology and treatment of HBV infection.
Maini MK; Gehring AJ
J Hepatol; 2016 Apr; 64(1 Suppl):S60-S70. PubMed ID: 27084038
[TBL] [Abstract][Full Text] [Related]
5. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
Zhu W; Liu H; Zhang X
ACS Infect Dis; 2019 May; 5(5):703-712. PubMed ID: 30907080
[TBL] [Abstract][Full Text] [Related]
6. HBV and the immune response.
Ferrari C
Liver Int; 2015 Jan; 35 Suppl 1():121-8. PubMed ID: 25529097
[TBL] [Abstract][Full Text] [Related]
7. Innate and adaptive immune responses in hepatitis B virus infection.
Das A; Maini MK
Dig Dis; 2010; 28(1):126-32. PubMed ID: 20460900
[TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis of chronic hepatitis B.
Balmasova IP; Yushchuk ND; Mynbaev OA; Alla NR; Malova ES; Shi Z; Gao CL
World J Gastroenterol; 2014 Oct; 20(39):14156-71. PubMed ID: 25339804
[TBL] [Abstract][Full Text] [Related]
9. Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.
Han Q; Lan P; Zhang J; Zhang C; Tian Z
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():132-7. PubMed ID: 23855309
[TBL] [Abstract][Full Text] [Related]
10. Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy.
de Niet A; Stelma F; Jansen L; Sinnige MJ; Remmerswaal EB; Takkenberg RB; Kootstra NA; Reesink HW; van Lier RA; van Leeuwen EM
J Hepatol; 2016 Mar; 64(3):539-46. PubMed ID: 26505119
[TBL] [Abstract][Full Text] [Related]
11. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.
Novotny LA; Evans JG; Su L; Guo H; Meissner EG
Viruses; 2021 Jun; 13(6):. PubMed ID: 34207487
[TBL] [Abstract][Full Text] [Related]
12. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.
Bertoletti A; Ferrari C
Gut; 2012 Dec; 61(12):1754-64. PubMed ID: 22157327
[TBL] [Abstract][Full Text] [Related]
13. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
Meng Z; Chen Y; Lu M
Front Immunol; 2019; 10():3127. PubMed ID: 32117201
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of HBV immune evasion.
Kuipery A; Gehring AJ; Isogawa M
Antiviral Res; 2020 Jul; 179():104816. PubMed ID: 32387476
[TBL] [Abstract][Full Text] [Related]
15. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
Koh S; Bertoletti A
Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
[TBL] [Abstract][Full Text] [Related]
16. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection.
Du Y; Wu J; Liu J; Zheng X; Yang D; Lu M
Front Immunol; 2022; 13():965018. PubMed ID: 35967443
[TBL] [Abstract][Full Text] [Related]
18. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy.
Chang J; Block TM; Guo JT
Antiviral Res; 2012 Dec; 96(3):405-13. PubMed ID: 23072881
[TBL] [Abstract][Full Text] [Related]
19. Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.
Suslov A; Wieland S; Menne S
Curr Opin Virol; 2018 Jun; 30():9-17. PubMed ID: 29444493
[TBL] [Abstract][Full Text] [Related]
20. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
Wang FS; Zhang Z
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
